Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 15 | Rare Historical Photos

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The Independent UK

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

The Week

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Tribune News Service

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

Wales Online

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Wales Online

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Manchester Evening News

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Independent UK

‘A silver lining’: how Covid ushered in a vaccines golden era

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

The Guardian - UK

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

The Guardian - UK

Being Vaccinated Halves Risk Of Long COVID: Study

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Zenger

Lisa Jarvis: An urgently needed TB shot could democratize vaccines

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Sen. Bernie Sanders shows fire, but seeks modest goals, in his debut drug hearing as health chair

Sen. Bernie Sanders, who rose to national prominence criticizing big business in general and the pharmaceutical industry in particular, claimed the spotlight Wednesday on what might at first seem a powerful new stage from which to advance his agenda: chairmanship of the Senate health committee.

Los Angeles Times

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Roll Call

Photos of the week ending March 24, 2023 - Roll Call

Photos of the week: Congress returned to Washington for a shortened work week this week.

Tribune News Service

Moderna CEO grilled by Senate panel over planned price hike

WASHINGTON — Moderna CEO Stéphane Bancel attempted on Wednesday to win over lawmakers irate about the company’s planned COVID-19 vaccine price increase, weathering a barrage of criticism from Democrats angry at the company’s profits from its groundbreaking mRNA vaccine.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Guardian - UK

Sunak’s tax return: the questions that remain unanswered

Details of his blind management arrangement and what offshore interests the prime minister has are still unclear

Fortune

Moderna faces criticism as it prices COVID vaccine at $130 per dose

Pfizer has said it’s considering a similar price for its vaccine.

Roll Call

Moderna CEO grilled by Senate panel over planned price hike - Roll Call

In a Senate hearing, Moderna's CEO tried to soothe lawmakers angry about plans to increase the cost of COVID-19 vaccines.

Tribune News Service

Moderna paid the US more than enough for COVID shot partnership, executive says

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

Salon

Sanders: "Medicare for All" must wait

As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma

WEKU

Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.